Top Markets
#1 TENDIES TENDIES +43.38%
#2 Cash Cat Cash Cat +27.85%
#3 ICON ICON +27.68%
#4 Threshold Network Threshold Network +20.99%
#5 OSK OSK +15.90%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Asteroid Shiba Asteroid Shiba +12.61%
#8 Magma Finance Magma Finance +11.78%
#9 MarsCoin MarsCoin +11.06%
#10 Kite Kite +10.66%
Coin of the day
TENDIES TENDIES
Instellingen
Taal
DUTCH
Valuta
USD
Thema
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rang in aandelen #16725
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Aandeelprijs
$3.78
Laatst gesynchroniseerd: 2026-03-17
Marktkapitalisatie
$276.54M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
45.53%
Land
CA
Handel NervGen Pharma Corp. (NGEN)

Categorie

Healthcare
EPS voor NervGen Pharma Corp. (NGEN)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van NervGen Pharma Corp. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van NervGen Pharma Corp. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH